Completed PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT01933464

An Analysis of the Effect of Topical Cromolyn Sodium on Rosacea-associated Erythema

Sponsor: University of California, San Diego

Interventions Cromolyn Sodium Normal Saline

Updated 10 times since 2017 Last updated: Jul 29, 2019 Started: Aug 31, 2013 Primary completion: Feb 28, 2014 Completion: Apr 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1/PHASE2 trial investigates Papulopustular Rosacea and is currently completed. University of California, San Diego leads this study, which shows 10 recorded versions since 2013 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2023 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Dec 2022 — Jan 2023 [monthly]

Completed PHASE1_PHASE2
Jan 2021 — Dec 2022 [monthly]

Completed PHASE1_PHASE2

▶ Show 5 earlier versions

Sep 2019 — Jan 2021 [monthly]

Completed PHASE1_PHASE2
Aug 2019 — Sep 2019 [monthly]

Completed PHASE1_PHASE2

Status: Unknown Status → Completed
Jun 2018 — Aug 2019 [monthly]

Unknown Status PHASE1_PHASE2
Feb 2017 — Jun 2018 [monthly]

Unknown Status PHASE1_PHASE2
Jan 2017 — Feb 2017 [monthly]

Unknown Status PHASE1_PHASE2

First recorded

Aug 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of California, San Diego

Data source: University of California, San Diego

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• San Diego, United States